超级增强剂在皮膜黑色素瘤中协调转录失调和代谢重编程
Hui Pan1,2, Weihuan Shao1,2, Huixue Wang2,3
1State Key Laboratory of Eye Health, Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Communications biology
|June 23, 2025
概括
这项研究揭示了皮膜黑色素瘤 (UM) 的超强增强器表观遗传途径,确定转录因子AP-2α (TFAP2A) 作为关键调节器. 这一发现为新的精确疗法提供了潜力,这些疗法针对UM的表观遗传脆弱性.
科学领域:
- 在瘤学瘤学.
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- 分子生物学分子生物学
背景情况:
- 卵巢黑色素瘤 (UM) 是最常见的成人眼内恶性瘤,具有高转移潜力.
- 虽然已知遗传因素,但UM病变的表观遗传基础尚未完全理解.
- 了解表观遗传机制对于开发有效的UM治疗至关重要.
研究的目的:
- 使用超级增强剂介导管道调查UM的表观遗传景观.
- 为了确定驱动UM病变的关键转录因素.
- 探索针对性治疗的潜在表观遗传漏洞.
主要方法:
- 基因组规模的素乙化和转录分析.
- 染色体免疫沉测序 (ChIP-seq) 来绘制超级增强剂的地图.
- 识别和分析与UM特定超级增强剂相关的主转录因子.
主要成果:
- 为UM建立了一个超级增强剂介导的表观遗传管道.
- 转录因子AP-2α (TFAP2A) 被确定为UM中的关键调节者.
- 发现TFAP2A通过超级增强剂调节瘤基因SLC7A8,将其与瘤发生和新陈代谢联系起来.
结论:
- 超级增强剂在UM病变发生过程中发挥着重要作用.
- TFAP2A是UM的一个关键表观遗传驱动器,调节基因表达.
- 针对超强增强剂介导的瘤基因依赖性是一种有前途的战略,用于UM的精密治疗.
相关概念视频
Induced Pluripotent Stem Cells
4.4K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.4K
Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
Abnormal Proliferation
4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Epigenetic Regulation
3.1K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.1K
Mitogens and the Cell Cycle
7.0K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.0K


